NeoGenomics NEO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$99.21M+8.2% | -$108.03M+4.8% | -$113.47M-9.1% | -$104.04M-34.1% | -$77.59M+1.4% | ||
| $35.49M-1.6% | $36.07M-2.9% | $37.14M-2.2% | $37.96M-1.6% | $38.56M-1.4% | ||
| $40.2M-2.7% | $41.32M-0.7% | $41.6M+32.9% | $31.3M+12.1% | $27.92M+11.9% | ||
| $22.42M+329% | $5.23M-61.8% | $13.69M— | —— | —— | ||
| $27.51M+1.9% | $27.01M-12.1% | $30.74M-7.5% | $33.22M-16.9% | $39.98M-2.6% | ||
| -$20.9M-69.4% | -$12.34M— | —— | —— | —— | ||
| —— | —— | —— | -$199.62M-4,277% | $4.78M+2.9% | ||
| -$209.45M+3.4% | -$216.79M-4.6% | -$207.27M-3.4% | -$200.36M-1,503% | $14.28M-41.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
